Tempus Receives U.S. FDA Approval for xT CDx, a NGS-Based In

Tempus Receives U.S. FDA Approval for xT CDx, a NGS-Based In Vitro Diagnostic Device

Tempus Receives U.S. FDA Approval for xT CDx, a NGS-Based In Vitro Diagnostic Device
webwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from webwire.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Chicago , Illinois , United States , Eric Lefkofsky , Drug Administration , Tempus Labs Inc , Based In Vitro Diagnostic , Premarket Approval , Next Generation Sequencing , Companion Diagnostic Indications , Tempus Labs , Press Release Image , Tempus , Leader , Rtificial , Intelligence , Precision , Medicine , Wood , Drug , Administration , Fda , Approved , Ompanys , Premarket , Approval , Ma , Application , Companion , Iagnostic , Pest , It , Dx , 48 Gene , Next Generation , Sequencing , Olid , Humor , Profiling , Ncludes , Microsatellite , Instability , Status , Claims , Olorectal , Dancer , Patients , Significant , Milestone , Ontinue , Ebwire , Press Release , Ews Release ,